Pharmaceuticals

Global healthcare awareness is on the rise. However, the winners in this segment may not be in traditional areas!

There were some strong moves in the Pharma and Biotech sector in May, with the share prices of 33 companies in the coverage universe rising by 10% or more. Below we...

Markets were more subdued in April after the strong start to the year. The S&P/ASX 200 Accumulation Index was down 2.9% and the S&P/ASX Small Ordinaries Accumulation...

Uncovering hidden gems amidst the sea of opportunities often requires a keen eye for potential change and growth catalysts.

The Pharma and Biotech market was relatively buoyant in March with 49% of share prices in the coverage universe increasing for the month. There was some...

Below, we take a look at four stocks that have been amongst the best performers in the first two months of the new year.

There was some significant news flow in November 2023 which saw the shares of a number of pharma and biotech companies rally strongly. The share price of three...

We weigh the latest blockbuster weight-loss drugs against pharmaceuticals (and others) that have gone before

Breakthroughs in obesity drugs look extraordinarily profitable for 2 stocks. But, with improvements, a raft of sectors might be affected.

It was a tough month for the Pharma & Biotech coverage universe with 73.2% of share prices for companies in the universe either flat or negative for the month of...